Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04655365
Title Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. (PROSTEP-002)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.